Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO

About

Dr. Reddy’s Laboratories Limited (DRL) is an integrated global pharmaceutical company. The Company operates in three segments: Global Generics segment, which includes its prescription and over-the-counter (OTC) drug products business; Pharmaceutical Services and Active Ingredients (PSAI) segment, which consists of its active... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	0.69
Market Cap (Mil.):	Rs385,001.09
Shares Outstanding (Mil.):	170.07
Dividend:	15.00
Yield (%):	0.66

Financials

	REDY.BO	Industry	Sector
P/E (TTM):	22.96	32.01	33.02
EPS (TTM):	98.58	--	--
ROI:	20.37	19.61	19.07
ROE:	25.71	20.45	20.00

Latest News about REDY.BO

India's NSE index hits 28-month high

MUMBAI, May 11 - India's NSE index rose marginally on Saturday to its highest level since January 2011, led by Dr. Reddy's Laboratories Ltd, and ITC Ltd ahead of their quarterly earnings releases next week. The broader NSE index rose 0.21 percent, or 12.50 points, to end at 6,107.25. The benchmark BSE index rose 0.20 percent, or 39.70 points, to end at 20,122.32. Shares in Dr. Reddy's Laboratories stock rose 3.85 percent, while ITC ended 0.28 percent higher. The market was

11 May 2013

» More REDY.BO News

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Thomson Reuters Stock Report - DR REDDYS LABORATORIES LIMITED (DRREDDY-IN) Provider: Thomson Reuters Stock Report	$25.00 Buy
Dr. Reddy's Labs ADS Provider: S&P Capital IQ – STARS Reports	$115.00 Buy
Dr.Reddy's Laboratories Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
DR REDDY S LABORATORIES INC (RDY) 12-months forecast Provider: Pechala's Reports	$15.00 Buy
Dr.Reddy's Laboratories Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.